ASCENT, NCT06129240: An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH |
|
|
| Recruiting | N/A | 60 | US | LIQ861 | Liquidia Technologies, Inc. | Pulmonary Hypertension, Interstitial Lung Disease | 07/26 | 10/26 | | |
| Recruiting | N/A | 135 | US | | National Jewish Health, University of California, Davis, Mayo Clinic, University of Chicago, University of Texas Southwestern Medical Center, University of Arizona, University of Utah | Hypersensitivity Pneumonitis | 01/25 | 01/26 | | |
